Related
Menu

gm 3 lactone

Immunogenic synthetic glycoconjugate for the immunotherapy of melanoma
managed by Office for the Valorization of Biomedical and Pharmaceutical Research (UVaR)
TRL: 4
Availability: other
Status: US Patent
Life sciences, Medicine
Details

EU-Japan Centre's News

More
The Centre's December 2024 newsletter is out !
The Centre quarterly newsletter, December 2024 issue, is out! In this issue:   Call for…
Weekly Japanese Industry and Policy News: 14 Dec - 20 Dec 2024
The EU Japan Centre is releasing a weekly press review covering Japan's economic and policy matters…
Weekly Japanese Industry and Policy News: 07 Dec - 13 Dec 2024
The EU Japan Centre is releasing a weekly press review covering Japan's economic and policy matters…

Events

More
Japan
21/01/2025 - 24/01/2025
Smart Factory & Robotics Business Mission
Are you running a business specialising in smart factory solutions, manufacturing and robotics technologies? Would you like to present your technologies and products to potential partners and clients…
Japan
29/01/2025 - 31/01/2025
Space Business Mission in Japan
--- Applications are now closed --- Are you a European business specialising in lunar or deep space exploration, satellite equipment, upstream or ground-based space-related technologies and…

Library

Interested in being updated as to the helpdesk's activities?

By subscribing to the Newsletter, you will get constant updates about:

  • available technologies
  • recent changes in IP law
  • webinars and seminars
  • articles and presentations
Subscribe
Helpdesk links

EU-Japan Centre for Industrial Cooperation

Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.

 

The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026

Copyright © 2024 EU-Japan Centre